SPF66 - THE FIRST MALARIA VACCINE

被引：30
|
作者：
TANNER, M
TEUSCHER, T
ALONSO, PL
机构：
[1] NATL INST MED RES,IFAKARA CTR,IFAKARA,TANZANIA
[2] HOSP CLIN BARCELONA,UNIDAD EPIDEMIOL,BARCELONA,SPAIN
来源：
PARASITOLOGY TODAY | 1995年 / 11卷 / 01期
关键词：
D O I：
10.1016/0169-4758(95)80098-0
中图分类号：
R38 [医学寄生虫学]; Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ; 100103 ;
摘要：
A crucial step has been mane in the development of malaria vaccines. The first trial of SPf66 in Africa and the first outside Latin America has been completed in an area of very intense and perennial transmission. In this review, Marcel Tanner, Thomas Teuscher and Pedro Alonso briefly discuss the success and the limitations of SPf66, the questions which remain open and the prospects for further development and application.
引用
下载
收藏
页码：10 / 13
页数：4
相关论文
共 50 条
  • [21] Phase I trial of the SPF66 malaria vaccine in a malaria-experienced population in Southeast Asia
    Nosten, F
    Luxemburger, C
    Kyle, DE
    Gordon, DM
    Ballou, WR
    Sadoff, JC
    Brockman, A
    Permpanich, B
    Chongsuphajaisiddhi, T
    Heppner, DG
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 56 (05): : 526 - 532
  • [22] VACCINATION WITH SPF66, A CHEMICALLY SYNTHESIZED VACCINE, AGAINST PLASMODIUM-FALCIPARUM MALARIA IN COLOMBIA
    VALERO, MV
    AMADOR, LR
    GALINDO, C
    FIGUEROA, J
    BELLO, MS
    MURILLO, LA
    MORA, AL
    PATARROYO, G
    ROCHA, CL
    ROJAS, M
    APONTE, JJ
    SARMIENTO, LE
    LOZADA, DM
    CORONELL, CG
    ORTEGA, NM
    ROSAS, JE
    ALONSO, PL
    PATARROYO, ME
    LANCET, 1993, 341 (8847): : 705 - 710
  • [23] Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania
    Acosta, CJ
    Galindo, CM
    Schellenberg, D
    Aponte, JJ
    Kahigwa, E
    Urassa, H
    Schellenberg, JRMA
    Masanja, H
    Hayes, R
    Kitua, AY
    Lwilla, F
    Mshinda, H
    Menendez, C
    Tanner, M
    Alonso, PL
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1999, 4 (05) : 368 - 376
  • [24] RIGHTS TO SPF66
    MAURICE, J
    LANCET, 1995, 345 (8959): : 1232 - 1232
  • [25] SPF66, A CHEMICALLY SYNTHESIZED SUBUNIT MALARIA VACCINE, IS SAFE AND IMMUNOGENIC IN TANZANIANS EXPOSED TO INTENSE MALARIA TRANSMISSION
    TEUSCHER, T
    SCHELLENBERG, JRMA
    DEAZEVEDO, IB
    HURT, N
    SMITH, T
    HAYES, R
    MASANJA, H
    SILVA, Y
    LOPEZ, MC
    KITUA, A
    KILAMA, W
    TANNER, M
    ALONSO, PL
    VACCINE, 1994, 12 (04) : 328 - 336
  • [26] Humoral immune response to the anti-malaria vaccine SPf66 in the Colombian Atrato river region
    Lopera, TM
    Restrepo, M
    Blair, S
    Garcia, HI
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1998, 93 (04): : 495 - 500
  • [27] An efficacy trial of the malaria vaccine SPf66 in Gambian infants - second year of follow-up
    Bojang, KA
    Obaro, SK
    DAlessandro, U
    Bennett, S
    Langerock, P
    Targett, GAT
    Greenwood, BM
    VACCINE, 1998, 16 (01) : 62 - 67
  • [28] RANDOMIZED TRIAL OF SPF66 VACCINE AGAINST PLASMODIUM-FALCIPARUM MALARIA IN CHILDREN IN SOUTHERN TANZANIA - COMMENT
    WHITE, NJ
    JOURNAL OF PEDIATRICS, 1995, 126 (03): : 499 - 499
  • [29] STUDY OF THE SAFETY AND IMMUNOGENICITY OF THE SYNTHETIC MALARIA SPF66 VACCINE IN CHILDREN AGED 1-14 YEARS
    PATARROYO, G
    FRANCO, L
    AMADOR, R
    MURILLO, LA
    ROCHA, CL
    ROJAS, M
    PATARROYO, ME
    VACCINE, 1992, 10 (03) : 175 - 178
  • [30] THE 1ST FIELD TRIALS OF THE CHEMICALLY SYNTHESIZED MALARIA VACCINE SPF66 - SAFETY, IMMUNOGENICITY AND PROTECTIVITY
    AMADOR, R
    MORENO, A
    VALERO, V
    MURILLO, L
    MORA, AL
    ROJAS, M
    ROCHA, C
    SALCEDO, M
    GUZMAN, F
    ESPEJO, F
    NUNEZ, F
    PATARROYO, ME
    VACCINE, 1992, 10 (03) : 179 - 184
12345